Draig Therapeutics has been awarded £107m to advance the development of novel therapies for major neuropsychiatric disorders ...

Hurricane Erick strengthened in the Pacific Ocean and could become a major hurricane before striking Mexico, the National ...

Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

According to Ni, ketamine and the products that it breaks down into are released through our urine and can therefore ...

More than 40% of patients with systemic lupus erythematosus in a large international study reported insufficient levels of physical activity, with low activity levels correlated to worsening of ...

Studies have found that rest improves memory and can literally grow our brains. Neuroscientist Dr Joseph Jebelli reveals how ...

New Cardiff University spin-out, Draig Therapeutics, receives $140 Million investment in developing new therapies for Major Neuropsychiatric Disorders ...

A biotech company founded in Wales last year has raised $140mn in its first financing round to develop drugs for severe ...

On today’s edition of “CT BUZZ,” Reporter Jillian Andrews sat down with Jayesh Kamath, MD, PhD, Director of the Psychiatry ...

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...